Nasus Pharma Ltd. (NSRX) ownership: Top institutional holder: Balyasny Asset Management L.P. ($1.99M). Insider activity: Net Seller (0 buys, 2 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Balyasny Asset Management L.P. | 898473.00 | $1.99M | 2026-03-31 |
| Cable Car Capital, LP | 601998.00 | $1.34M | 2026-03-31 |
| Velan Capital Investment Management LP | 359390.00 | $797846.00 | 2026-03-31 |
| Hudson Bay Capital Management LP | 134771.00 | $299192.00 | 2026-03-31 |
| Bleichroeder LP | 89848.00 | $199463.00 | 2026-03-31 |
| Empery Asset Management, LP | 45803.00 | $101683.00 | 2026-03-31 |
| HRT FINANCIAL LP | 38897.00 | $86000.00 | 2026-03-31 |
| UBS Group AG | 3094.00 | $6869.00 | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-04-22 | |
| Sell | null | 2026-03-31 |
Back to NSRX overview · NSRX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.